FLGT — Fulgent Genetics Share News
0.000.00%
- $587.18m
- $328.54m
- $322.67m
Fulgent Genetics Inc expected to post a loss of 43 cents a share - Earnings Preview
Brief: Mission Bio Partners With Fulgent Genetics To Broaden Accessibility Of Single-Cell Multi-Omics
U.S. RESEARCH ROUNDUP-Brown-Forman, Lam Research, PPG Industries
Fulgent Genetics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Fulgent Reports Fourth Quarter And Full Year 2022 Financial Results
Fulgent Genetics Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Fulgent Adds Reggie Groves To Board Of Directors
Brief: Fulgent Genetics Receives Letter From Nasdaq For Not Being In Compliance With The Audit Committee Requirements
U.S. RESEARCH ROUNDUP-Coherent, Huntington Ingalls Industries, Spirit Aerosystems Holdings
Brief: Fulgent Genetics Inc Says Under Terms Of Agreement, Co Acquired Fulgent Pharma For A Total Purchase Price Of About $100 Mln
Fulgent Genetics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Fulgent Genetics Reports Third Quarter 2022 Financial Results
Fulgent Genetics Inc expected to post earnings of 5cents a share - Earnings Preview
Brief: Fulgent Genetics Announces Launch Of PCR Based Test To Detect Monkeypox
Fulgent Genetics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Fulgent Genetics Reports First Quarter 2022 Financial Results
Fulgent Genetics Inc expected to post earnings of $3.86 a share - Earnings Preview
Fulgent Genetics gains on forecast raise, buyout of Inform Diagnostics
Brief: Fulgent Genetics Agrees To Acquire Inform Diagnostics And Provides Preliminary First Quarter Revenue Results